HPLC 2026 highlights AI, 2D-LC, new materials, and pharma separations.
News|Articles|September 22, 2025
- LCGC E-Books-9-22-25
- Volume Sponsored eBook
Hot Topics in PFAS (Sept 2025)
Hot Topics in PFAS” from LCGC International, we provide a comprehensive overview of per- and polyfluoroalkyl substances (PFAS) analysis, highlighting the evolving analytical techniques, challenges, and regulatory landscape surrounding these persistent chemicals. Key analytical challenges, such as matrix effects, sample contamination, and the lack of commercial standards, are addressed, alongside innovations like matrix-matched semiquantification for complex samples and the use of specialized HPLC columns to retain ultra-short-chain PFAS.
Related to this article
Kinjal Bhatt and Ina Varfaj redefine career success around energizing work and personal balance, moving past publications and promotions.
Piotr Alvarez explains how his lab uses 2D-LC to enable MS compatibility with legacy methods and to confirm peak purity through orthogonal separation.
Florian Geistmann succeeded retiring Jürgen Semmler as Shimadzu Europa managing director on October 1.
Liquid chromatography-mass spectrometry (LC-MS) profiling reveals chemical diversity across grapevine varieties.
Liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) link perinatal factors to infant urinary metabolite changes.
This LCGC Blog installment explains how NIST categorizes and certifies reference materials, and why they underpin reliable results in science and medicine.
Comparing manual and automated N-glycan profiling of a trastuzumab biosimilar, researchers found that both workflows detected the same glycan types, but automation gave more reproducible results (mean CV of about 5.7% vs. 7.95%), making it better suited to high-throughput analysis in biopharmaceutical development.
Trending on LCGC International
1
HPLC Method Measures Fiber's Cholesterol Uptake
2
The LCGC Blog: NIST Reference Materials
3
Challenges and Solutions in Oligonucleotide Analysis, Part V: Troubles with Phosphorothioate Oligonucleotides
4
Automated Workflow Paves Way for High-Throughput Reproducible Operations—Trastuzumab Glycosylation Profiling as a Case Study
5